Miranda Davies
7PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 30, 2026
A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.Dawn Cooper, Mohammed Toseef Ansari, Taylor Aurelius
|May 02, 2025
Safety and utilisation of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine: a UK post-authorisation active surveillance study.Alison Evans, Debabrata Roy, Miranda Davies
|Mar 07, 2025
Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective.Amy Bobbins, Miranda Davies, Elizabeth Lynn
|Nov 05, 2020
Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study.Alison Evans, Miranda Davies, Vicki Osborne
|Jul 24, 2020
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice.Luis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg
|May 30, 2020
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.Miranda Davies, Vicki Osborne, Samantha Lane
Pageof 2
Frequent Collaborators
3 joint publications
Alison Evans
2 joint publications
Saad Shakir
2 joint publications
Debabrata Roy
1 joint publications
Luis Alberto García-Rodríguez
1 joint publications
Mari-Ann Wallander
1 joint publications
Leif Friberg
1 joint publications
Ana Ruigomez
1 joint publications
Tania Schink
1 joint publications
Irene Bezemer
1 joint publications
Ron Herings
